-
APMD share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of APMD shares has increased $0.89 since the market last closed. This is a 3.17% rise.
-
Last closed at $29.00.
The stock has since risen $0.40 in pre-market trading.
Key terms
About APMD
Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.
-
Market cap: $1.21B
A market capitalization between $300 million and $2 billion places APMD in the small capitalization category.
Key terms
Smart score
Latest APMD news
APMD Financials
-
APMD total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
APMD net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
APMD earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
APMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
APMD Competitors
-
How competitors are chosen
APMD's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.21B
A market capitalization between $300 million and $2 billion places APMD in the small capitalization category.
